Stock Analysis
CUC (TSE:9158) Full Year 2024 Results
Key Financial Results
- Revenue: JP¥33.0b (down 6.2% from FY 2023).
- Net income: JP¥2.60b (up 7.1% from FY 2023).
- Profit margin: 7.9% (up from 6.9% in FY 2023). The increase in margin was driven by lower expenses.
- EPS: JP¥93.98.
All figures shown in the chart above are for the trailing 12 month (TTM) period
CUC EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 30%.
Looking ahead, revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Healthcare industry in Japan.
Performance of the Japanese Healthcare industry.
The company's shares are down 23% from a week ago.
Risk Analysis
It is worth noting though that we have found 1 warning sign for CUC that you need to take into consideration.
Valuation is complex, but we're helping make it simple.
Find out whether CUC is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:9158
CUC
CUC Inc. offers healthcare services in Japan, Asia and internationally.
Adequate balance sheet with moderate growth potential.